MusclePharm to Acquire BioZone Pharmaceuticals’ QuSomes® Technology and Manufacturing Facilities

MusclePharm Corporation (OTCQB:MSLP), an international sports nutrition company, announced today it has signed a definitive asset purchase agreement with BioZone Pharmaceuticals, Inc. to acquire substantially all of the assets of BioZone and its subsidiaries.

As quoted in the press release:

BioZone’s patented QuSomes® technology enhances the absorption of topical and other drugs. MusclePharm is evaluating the QuSomes® technology in connection with nutritional supplements to determine if the combination of QuSomes® and nutritional supplements will enhance the absorption and speed of delivery of several MusclePharm products.

Click here for the full press release by MusclePharm (OTCQB:MSLP)